Literature DB >> 23430825

First report of a molecular prenatal diagnosis in a tunisian family with lysinuric protein intolerance.

Nadia Esseghir1, Chiraz Souissi Bouchlaka, Sondess Hadj Fredj, Amel Ben Chehida, Hatem Azzouz, Monique Fontaine, Neji Tebib, Marie Françoise Ben Dridi, Gilbert Briand, Taieb Messaoud, Amel Ben Ammar Elgaaied, Naziha Kaabachi.   

Abstract

Lysinuric protein intolerance (LPI, MIM# 222700) is an inherited aminoaciduria caused by defective transport of cationic amino acids (CAAs; arginine, lysine, ornithine) at the basolateral membrane of epithelial cells in the intestine and kidney. We report the first prenatal diagnosis by direct mutational analysis of LPI performed in a Tunisian family. An amniotic fluid sample was carried out at 16 weeks of gestation in a 32-year-old Tunisian woman who consulted for prenatal diagnosis. The 1471 delTTCT mutation at homozygous state was identified indicating that the fetus was affected by LPI. The identification of this specific mutation provides a tool, which can be easily applied in Tunisia for molecular diagnosis, genetic counseling, and prenatal diagnosis of LPI.

Entities:  

Year:  2011        PMID: 23430825      PMCID: PMC3509814          DOI: 10.1007/8904_2011_13

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  6 in total

1.  Protein intolerance with deficient transport of basic aminoacids. Another inborn error of metabolism.

Authors:  J Perheentupa; J K Visakorpi
Journal:  Lancet       Date:  1965-10-23       Impact factor: 79.321

Review 2.  Lysinuric protein intolerance: update and extended mutation analysis of the SLC7A7 gene.

Authors:  Maria Pia Sperandeo; Generoso Andria; Gianfranco Sebastio
Journal:  Hum Mutat       Date:  2008-01       Impact factor: 4.878

3.  First reported case of lysinuric protein intolerance (LPI) in Lithuania, confirmed biochemically and by DNA analysis.

Authors:  Loreta Cimbalistiene; Willy Lehnert; Kirsi Huoponen; Vaidutis Kucinskas
Journal:  J Appl Genet       Date:  2007       Impact factor: 3.240

4.  Novel SLC7A7 large rearrangements in lysinuric protein intolerance patients involving the same AluY repeat.

Authors:  Mariona Font-Llitjós; Benjamín Rodríguez-Santiago; Meritxell Espino; Ruth Sillué; Sandra Mañas; Laia Gómez; Luis A Pérez-Jurado; Manuel Palacín; Virginia Nunes
Journal:  Eur J Hum Genet       Date:  2008-08-20       Impact factor: 4.246

5.  Feasibility of prenatal diagnosis of lysinuric protein intolerance by linkage analysis: a case report.

Authors:  M P Sperandeo; A Buoninconti; A Passariello; I Scala; A Adami; T Lauteala; J Mykkänen; G Andria; G Sebastio
Journal:  Prenat Diagn       Date:  1999-08       Impact factor: 3.050

6.  Structure of the SLC7A7 gene and mutational analysis of patients affected by lysinuric protein intolerance.

Authors:  M P Sperandeo; M T Bassi; M Riboni; G Parenti; A Buoninconti; M Manzoni; B Incerti; M R Larocca; M Di Rocco; P Strisciuglio; I Dianzani; R Parini; M Candito; F Endo; A Ballabio; G Andria; G Sebastio; G Borsani
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

  6 in total
  3 in total

Review 1.  Overview of symptoms and treatment for lysinuric protein intolerance.

Authors:  Atsuko Noguchi; Tsutomu Takahashi
Journal:  J Hum Genet       Date:  2019-06-18       Impact factor: 3.172

2.  Heterogeneous colonic content: A prenatal sonographic manifestation of lysinuric protein intolerance.

Authors:  Christos Dimitriou; Souha Saliba; Xavier Peyrassol; Wafa Ben Abbou; Marie Cécile Nassogne; Carine Neugroschl; Elsa Wiame; Anne De Leener; Marie Cassart
Journal:  Clin Case Rep       Date:  2020-03-06

3.  Immune Dysregulation Mimicking Systemic Lupus Erythematosus in a Patient With Lysinuric Protein Intolerance: Case Report and Review of the Literature.

Authors:  Josefina Longeri Contreras; Mabel A Ladino; Katherine Aránguiz; Gonzalo P Mendez; Zeynep Coban-Akdemir; Bo Yuan; Richard A Gibbs; Lindsay C Burrage; James R Lupski; Ivan K Chinn; Tiphanie P Vogel; Jordan S Orange; M Cecilia Poli
Journal:  Front Pediatr       Date:  2021-05-20       Impact factor: 3.418

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.